View from the Thoraxcenter: ESC 24 Hot Line W...

In this Redcliffe Cardiology NVM reflections episode, Prof Nicolas Van Mieghem cuts through the noise from TCT 2025. Tune in to hear what the SELUTION trials mean for drug-coated balloons in de novo disease and ISR, why cost and sizing matter in calcium modification, how PE throm ...  Show more

At TCT 2025, Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr. Rahul P. Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease. The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricu ...  Show more

Join our hosts Can Gollmann-Tepeköylü and Miia L Lehtinen for their late-breaking trials highlights presented at the 37th EACTS Annual Meeting in Vienna, including: 

In this special ESC Congress episode of Eagle’s Eye View, Drs. Deepak Bhatt, Payal Kohli, and Philippe Gabriel Steg discuss highlights from Day 1 of the ESC Congress 2022: late-breaking science and featured clinical research, including SECURE, ENTRIGUE, TIME, and REDUCE-IT. 

Dr. Seemant Chaturvedi discusses this year's European Stroke Organization Conference and pivotal trials that were presented during the conference. Read the related content on the ESOC Plenary Highlights page. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more ...  Show more

<span style="font-family: helvetica; font-size: 10pt;">A Discussion of Epicardial Roof-Dependent Macro-Reentrant Tachycardia. Jason T. Jacobson, MD, FHRS of Westchester Medical Center – New York Medical College and co-host Danesh Kella, MBBS, FHRS of the Mayo Clinic Jacksonvil ...